JANINE SULAVIK: Open Payments
NPI 1881220994 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,632 in 168 payments from 21 companies in 2025. Trend: 2023 $2,625 · 2024 $3,213 · 2025 $3,632
Food & beverage: $3,415Education: $200Travel & lodging: $16
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $644 |
| Lilly USA, LLC | 18 | $495 |
| Galderma Laboratories, L.P. | 29 | $486 |
| Organon LLC | 14 | $306 |
| ABBVIE INC. | 17 | $279 |
| GENZYME CORPORATION | 7 | $244 |
| Arcutis Biotherapeutics, Inc. | 15 | $210 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $182 |
| Novartis Pharmaceuticals Corporation | 6 | $165 |
| Incyte Corporation | 5 | $117 |
Products named: TREMFYA, TALTZ, NEMLUVIO, DUPIXENT, Zoryve, VTAMA, SKYRIZI, ILUMYA.
Industry payments across IN — which companies pay providers there.
